Charles River Laboratories | CRL - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
Agilent USD 845M 7M 2026-03
Align Technology USD 298.76M 4.74M 2026-06
Bio-Rad Laboratories USD 305.2M 22.5M 2026-06
Bruker USD 422.5M 21.1M 2026-06
Cardinal Health USD 58.54B 4.82B 2026-03
Charles River Laboratories USD 655.29M 61.22M 2026-06
Cigna USD 65.13B 2.72B 2026-06
Concord Medical Services Hldg CNY 229.8M 24.9M 2025-12
CVS Health USD 90.35B 5.54B 2026-06
Danaher USD 2.65B 294M 2026-06
Dentsply International USD 405M 48M 2026-06
Elevance Health USD 38.07B 75M 2025-12
Humana USD 26.54B 1.15B 2025-03
Illumina USD 389M 19M 2026-06
Incyte USD 104.96M 457K 2026-06
Intrexon USD 1.01M 344K 2024-06
IQVIA Holdings USD 3.22B 141M 2026-06
Laboratory Of America USD 2.7B 97.8M 2026-06
Lakefront Biotherapeutics EUR 4.8M 4.34M 2026-03
Lonza CHF 2.28B 189M 2025-06
McKesson USD 101.7B 9.44B 2026-06
Merck EUR 2.27B 199M 2026-06
Mettler Toledo International USD 396.52M 14.4M 2026-06
Novartis USD 3.71B 251M 2026-06
Pfizer USD 4.09B 498M 2026-06
Quest Diagnostics USD 2.05B 64M 2026-06
Revvity USD 312.82M 10.64M 2026-06
Thermo Fisher Scientific USD 7.54B 577M 2026-06
United Therapeutics USD 99.5M 33.9M 2026-06
UnitedHealth USD 86.31B 8.41B 2026-03
Veradigm USD 124.74M 56.25M 2022-12
Waters USD 1.16B 430M 2026-06
West Pharmaceutical Services USD 543.1M 5.4M 2026-06